Charles Schwab Trust Co reduced its position in CME Group Inc. (NASDAQ:CME - Free Report) by 37.6% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 4,399 shares of the financial services provider's stock after selling 2,654 shares during the quarter. Charles Schwab Trust Co's holdings in CME Group were worth $1,167,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its stake in CME Group by 1.0% during the fourth quarter. Vanguard Group Inc. now owns 34,243,090 shares of the financial services provider's stock worth $7,952,273,000 after buying an additional 326,623 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of CME Group by 1.3% during the 4th quarter. Geode Capital Management LLC now owns 8,389,442 shares of the financial services provider's stock worth $1,946,717,000 after acquiring an additional 104,697 shares during the period. Price T Rowe Associates Inc. MD boosted its position in shares of CME Group by 89.9% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 8,280,785 shares of the financial services provider's stock valued at $1,923,047,000 after acquiring an additional 3,921,278 shares during the last quarter. Norges Bank purchased a new stake in shares of CME Group in the fourth quarter valued at about $1,107,389,000. Finally, FIL Ltd increased its position in CME Group by 1.5% during the fourth quarter. FIL Ltd now owns 4,081,391 shares of the financial services provider's stock worth $947,821,000 after purchasing an additional 61,908 shares during the last quarter. Hedge funds and other institutional investors own 87.75% of the company's stock.
Insider Transactions at CME Group
In other news, Director Howard J. Siegel sold 10,000 shares of the business's stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $260.00, for a total transaction of $2,600,000.00. Following the completion of the transaction, the director now directly owns 21,873 shares of the company's stock, valued at approximately $5,686,980. The trade was a 31.37% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Derek Sammann sold 4,650 shares of the business's stock in a transaction that occurred on Monday, May 5th. The stock was sold at an average price of $280.61, for a total transaction of $1,304,836.50. Following the transaction, the insider now owns 8,336 shares of the company's stock, valued at $2,339,164.96. This trade represents a 35.81% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 22,900 shares of company stock valued at $6,147,935. 0.30% of the stock is currently owned by company insiders.
CME Group Trading Down 0.2%
NASDAQ:CME traded down $0.66 on Friday, reaching $274.24. 1,635,928 shares of the company's stock were exchanged, compared to its average volume of 2,184,401. The firm has a market capitalization of $98.82 billion, a price-to-earnings ratio of 28.36, a price-to-earnings-growth ratio of 6.76 and a beta of 0.45. CME Group Inc. has a 52-week low of $190.70 and a 52-week high of $290.79. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10. The business has a fifty day moving average of $271.45 and a 200-day moving average of $252.61.
CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, beating analysts' consensus estimates of $2.61 by $0.19. The firm had revenue of $1.64 billion during the quarter, compared to analysts' expectations of $1.56 billion. CME Group had a net margin of 57.52% and a return on equity of 13.62%. The business's quarterly revenue was up 10.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.50 earnings per share. As a group, analysts expect that CME Group Inc. will post 10.49 earnings per share for the current year.
CME Group Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th will be paid a $1.25 dividend. The ex-dividend date is Monday, June 9th. This represents a $5.00 annualized dividend and a dividend yield of 1.82%. CME Group's dividend payout ratio (DPR) is 50.30%.
Analyst Upgrades and Downgrades
CME has been the topic of several recent analyst reports. JPMorgan Chase & Co. decreased their target price on shares of CME Group from $223.00 to $211.00 and set an "underweight" rating on the stock in a report on Thursday, April 24th. UBS Group lifted their price target on shares of CME Group from $290.00 to $305.00 and gave the company a "buy" rating in a research report on Friday, April 25th. Raymond James upgraded CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 price objective for the company in a research report on Monday, March 10th. Piper Sandler raised their target price on CME Group from $275.00 to $283.00 and gave the stock an "overweight" rating in a research note on Tuesday, April 8th. Finally, Keefe, Bruyette & Woods increased their price target on CME Group from $265.00 to $273.00 and gave the stock a "market perform" rating in a report on Thursday, April 24th. Three investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $258.20.
Read Our Latest Report on CME Group
CME Group Company Profile
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Further Reading
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
